A new study paints one of the most detailed pictures of human brain development to date, opening the door to new tests and ...

FoundationOne CDx is now FDA-approved as the first companion diagnostic for tovorafenib, enabling targeted treatment for ...

Ketogenic therapy is a non-toxic nutritional approach, viewed as complementary or alternative, that uses a low-carbohydrate, high-fat diet to manage a range of cancers, including glioblastoma. In this ...

The mutation patterns left behind by polymerase ... IBS/UNIST team represent a significant step forward in understanding glioblastoma resistance and offer hope for new, more effective therapies.

Common genetic abnormalities in grade 2–3 gliomas (WHO classification) and secondary GBM were also found to include mutations in the isocitrate dehydrogenase (IDH) gene. 7 This finding not only ...

A genomewide mutational analysis might pave the way to personalizing brain tumor treatments based on ... Researchers previously found somatic mutations in the gene for isocitrate dehydrogenase ...

The mutation patterns left behind by polymerase ... IBS/UNIST team represent a significant step forward in understanding glioblastoma resistance and offer hope for new, more effective therapies.

The mutation patterns left behind by polymerase ... IBS/UNIST team represent a significant step forward in understanding glioblastoma resistance and offer hope for new, more effective therapies.

More information: Tomás A. Martins et al, Enhancing anti-EGFRvIII CAR T cell therapy against glioblastoma with a paracrine ...

Mutations can differ by age ... bevacizumab has very little radiographic effect in children with glioblastoma multiforme but a good response rate in adult glioblastoma multiforme even though ...